Tech Executive

DOWNLOAD RECORD   vCard | CSV | PDF
Name  
 
Company Name   XyloCor Therapeutics
Company Status   Private & Independent
Industry   Biopharmaceutical
Profile   Profile
Social Media  
Company News  
Facebook  
YouTube  
Funding History   Company Transaction List
Mailing Address   76 Longview Ln. 
Newtown Square, PA 19073
USA  Map
Phone   (888) 290-0081
Website   www.xylocor.com
Company Description   XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our lead product candidate, XC001, is in clinical development for patients with refractory angina for which there are no treatment options.
Investors  

Fountain Healthcare Partners

Life Sciences Partners

Longwood Fund

Lumira Capital

Sofinnova Ventures

Undisclosed

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.


PCI - Level1